BioSpace News Archive

Dimerix Limited, is pleased to announce that it has received ethics committee approval for a study in healthy volunteers to determine the pharmacokinetic properties of the novel extended release propagermanium tablet to be used in the Company’s DMX-200 Phase 2b trial in Chronic Kidney Disease.

Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, has appointed Dr. Istvan Udvaros as its Chief Medical Officer (CMO) with immediate effect.

Corindus Vascular Robotics today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, November 7, 2017.

Shimadzu Scientific Instruments (SSI) announces the release of its new IRSpirit Fourier Transform Infrared (FTIR) Spectrophotometer. The smallest and lightest FTIR instrument from Shimadzu, the IRSpirit provides unmatched functionality in its class of compact instruments and offers exceptional reliability in contaminat analysis identification tests and quantitative measurements.

In the third calendar quarter (3Q) and first nine months (9M) of 2017, Utah Medical Products, Inc. achieved results which confirm that the Company is very likely to significantly exceed its previously announced goals for 2017.

Irvine Scientific announced a new agreement with Sunlight Medical Inc., which gives Irvine Scientific US distribution rights for Sunlight Medical branded micropipettes.

Katena Products, a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of Rhein Medical Inc.

Samumed will be presenting data in three presentations at the 2017 ACR/ARHP Annual Meeting.